Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
0.00
+0.0230 (0.31%)
Apr 20, 2026, 9:31 AM EDT - Market open
Kezar Life Sciences Market Cap
Kezar Life Sciences has a market cap or net worth of $54.15 million as of April 20, 2026. Its market cap has increased by 61.13% in one year.
Market Cap
54.15M
Enterprise Value
-15.40M
1-Year Change
61.13%
Ranking
Category
Stock Price
n/a
Market Cap Chart
Since June 21, 2018, Kezar Life Sciences's market cap has decreased from $325.21M to $54.15M, a decrease of -83.35%. That is a compound annual growth rate of -20.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 54.15M | 17.56% |
| Dec 31, 2025 | 46.06M | -6.05% |
| Dec 31, 2024 | 49.03M | -28.81% |
| Dec 29, 2023 | 68.87M | -85.69% |
| Dec 30, 2022 | 481.38M | -41.42% |
| Dec 31, 2021 | 821.73M | 240.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 58.43M |
| Metagenomi Therapeutics | 55.68M |
| Dogwood Therapeutics | 55.45M |
| Actuate Therapeutics | 54.77M |
| Mereo BioPharma Group | 53.73M |
| Edesa Biotech | 52.69M |
| Nutriband | 52.27M |
| Radiopharm Theranostics | 52.23M |